SELLAS Life Sciences Group SLS
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q1 | 1.08 | 104.30 | -0.07 | -6,063 | -6 | |
| 2024Q4 | 1.04 | 102.69 | -0.08 | -6,918 | -7 | |
| 2024Q3 | 1.25 | 103.11 | -0.09 | -7,329 | -7 | |
| 2024Q2 | 1.19 | 102.02 | -0.12 | -7,621 | -7 | |
| 2024Q1 | 1.01 | 100.83 | -0.21 | -9,645 | -10 | |
| 2023Q4 | 1.06 | 100.50 | -0.25 | -8,177 | -8 | |
| 2023Q3 | 1.64 | 101.01 | -0.32 | -9,361 | -9 | |
| 2023Q2 | 1.57 | 102.38 | -0.30 | -9,050 | -9 | |
| 2023Q1 | 1.43 | 101.66 | -0.47 | -11,281 | -11 | |
| 2022Q4 | 2.36 | 103.56 | -0.43 | -9,446 | -9 | |
| 2022Q3 | 2.02 | 101.77 | -0.31 | -7,146 | -7 | |
| 2022Q2 | 2.23 | 102.48 | -0.34 | -8,623 | -8 | |
| 2022Q1 | 6.68 | 99.95 | -1.05 | -16,735 | -17 | |
| 2021Q4 | 5.53 | 169.99 | -0.42 | -11,619 | -7 | |
| 2021Q3 | 9.16 | 98.48 | -0.45 | -6,977 | -7 | |
| 2021Q2 | 11.10 | 96.53 | -0.31 | -4,453 | -5 | |
| 2021Q1 | 8.54 | 93.42 | -0.16 | -2,245 | -2 | |
| 2020Q4 | 5.81 | 111.41 | -0.28 | -4,159 | -4 | |
| 2020Q3 | 2.65 | 100.42 | -0.51 | -4,492 | -4 | |
| 2020Q2 | 2.93 | 96.43 | -0.66 | -4,267 | -4 |